Literature DB >> 12657679

Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.

Hiroaki Adachi1, Masahisa Katsuno, Makoto Minamiyama, Chen Sang, Gerassimos Pagoulatos, Charalampos Angelidis, Moriaki Kusakabe, Atsushi Yoshiki, Yasushi Kobayashi, Manabu Doyu, Gen Sobue.   

Abstract

Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of the polyglutamine (polyQ) tract within the androgen receptor (AR). The nuclear inclusions consisting of the mutant AR protein are characteristic and combine with many components of ubiquitin-proteasome and molecular chaperone pathways, raising the possibility that misfolding and altered degradation of mutant AR may be involved in the pathogenesis. We have reported that the overexpression of heat shock protein (HSP) chaperones reduces mutant AR aggregation and cell death in a neuronal cell model (Kobayashi et al., 2000). To determine whether increasing the expression level of chaperone improves the phenotype in a mouse model, we cross-bred SBMA transgenic mice with mice overexpressing the inducible form of human HSP70. We demonstrated that high expression of HSP70 markedly ameliorated the motor function of the SBMA model mice. In double-transgenic mice, the nuclear-localized mutant AR protein, particularly that of the large complex form, was significantly reduced. Monomeric mutant AR was also reduced in amount by HSP70 overexpression, suggesting the enhanced degradation of mutant AR. These findings suggest that HSP70 overexpression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR, probably caused by enhanced mutant AR degradation. Our study may provide the basis for the development of an HSP70-related therapy for SBMA and other polyQ diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657679      PMCID: PMC6742038     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.

Authors:  E E Wanker; E Scherzinger; V Heiser; A Sittler; H Eickhoff; H Lehrach
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome.

Authors:  J Lüders; J Demand; J Höhfeld
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

3.  PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival.

Authors:  M Waragai; C H Lammers; S Takeuchi; I Imafuku; Y Udagawa; I Kanazawa; M Kawabata; M M Mouradian; H Okazawa
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

4.  Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation.

Authors:  C Y Li; J S Lee; Y G Ko; J I Kim; J S Seo
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

5.  Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.

Authors:  Y Chai; S L Koppenhafer; N M Bonini; H L Paulson
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

6.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

Authors:  J M Warrick; H Y Chan; G L Gray-Board; Y Chai; H L Paulson; N M Bonini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

7.  Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.

Authors:  D L Stenoien; C J Cummings; H P Adams; M G Mancini; K Patel; G N DeMartino; M Marcelli; N L Weigel; M A Mancini
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

Review 8.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

9.  Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract.

Authors:  Y Kobayashi; A Kume; M Li; M Doyu; M Hata; K Ohtsuka; G Sobue
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

10.  Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor--gene expression level.

Authors:  F Tanaka; M F Reeves; Y Ito; M Matsumoto; M Li; S Miwa; A Inukai; M Yamamoto; M Doyu; M Yoshida; Y Hashizume; S Terao; T Mitsuma; G Sobue
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

View more
  78 in total

1.  Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.

Authors:  Yu Miyazaki; Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Yue-Mei Jiang; Zhe Huang; Hideki Doi; Shinjiro Matsumoto; Naohide Kondo; Madoka Iida; Genki Tohnai; Fumiaki Tanaka; Shin-ichi Muramatsu; Gen Sobue
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

Review 2.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

Review 3.  Aggregation formation in the polyglutamine diseases: protection at a cost?

Authors:  Tiffany W Todd; Janghoo Lim
Journal:  Mol Cells       Date:  2013-06-19       Impact factor: 5.034

Review 4.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

Review 5.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 6.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

7.  Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease.

Authors:  Jennifer L Wacker; Shao-Yi Huang; Andrew D Steele; Rebecca Aron; Gregor P Lotz; QuangVu Nguyen; Flaviano Giorgini; Erik D Roberson; Susan Lindquist; Eliezer Masliah; Paul J Muchowski
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

Review 8.  Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders.

Authors:  Serena Carra; Paola Rusmini; Valeria Crippa; Elisa Giorgetti; Alessandra Boncoraglio; Riccardo Cristofani; Maximillian Naujock; Melanie Meister; Melania Minoia; Harm H Kampinga; Angelo Poletti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-03-25       Impact factor: 6.237

Review 9.  The Role of the Protein Quality Control System in SBMA.

Authors:  Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Carlo Rinaldi; Maria Elena Cicardi; Mariarita Galbiati; Serena Carra; Bilal Malik; Linda Greensmith; Angelo Poletti
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 10.  Targeted Molecular Therapies for SBMA.

Authors:  Carlo Rinaldi; Bilal Malik; Linda Greensmith
Journal:  J Mol Neurosci       Date:  2015-11-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.